Lymphangioma: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
A '''lymphangioma''' is [[benign tumor]] of the [[lymphatic system]], usually due to a congenital malformation. It must not be confused with a malignant [[lymphangiosarcoma]]. | A '''lymphangioma''' is a [[benign tumor]] of the [[lymphatic system]], usually due to a congenital malformation. It must not be confused with a malignant [[lymphangiosarcoma]]. | ||
They may bleed, or their cells may die and support an infection. They may block body functions based on their location, so they should be removed. | They may bleed, or their cells may die and support an infection. They may block body functions based on their location, so they should be removed. | ||
Latest revision as of 17:48, 1 July 2010
A lymphangioma is a benign tumor of the lymphatic system, usually due to a congenital malformation. It must not be confused with a malignant lymphangiosarcoma.
They may bleed, or their cells may die and support an infection. They may block body functions based on their location, so they should be removed.
Surgery has been the mainstay of removing lymphangiomas, but sclerotherapy with bleomycin has been reported as successful. [1]
References
- ↑ Umair Khalid, Saulat Hasnain Fatimi, Taimur Saleem, "Giant unresectable Lymphangioma of the trunk managed via intra-tumour injections of bleomycin", Journal of Pakistan Medical Association